Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-008568

Chief Financial Officer acquired 17,063 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Koppikar Utpal Chief Financial Officer 2019-02-06 Grant or award +17,063 64,063 D
Derivatives
Koppikar Utpal Chief Financial Officer 2019-02-06 Grant or award · Employee Stock Option (Right to Buy) +34,125 34,125 D
Loading xslF345X03/doc4.xml…